PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancerSandeep Rajput, X. Cynthia|Oncotarget|2019Cited by 11
Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, X. Cynthia, Shunqiang Li et al.|Unknown|2023Cited by 0